Middle East Pharmaceutical Industries Co
Country : Saudi Arabia
Sector : pharmaceuticals Research and Biotechnology
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Middle East Pharmaceutical Industries Co Profile

Last Review Date 26-Nov-2023

Basic Information

  • Activity :
    Middle East Pharmaceutical Industries Co. (known as: AVALON PHARMA) is a public company, listed on Saudi Exchange “Tadawul” (TDWL) since Februry 2024. AVALON PHARMA operats within the pharmaceuticals Research...
  • Industry Group :
    Pharmaceuticals and Biotechnology Research & Development
  • Sub-Industry :
  • Contact Person :
  • Established On :
    08-Feb-2021
  • No of Employees :
    450 Employees as of 2019
  • Authorized Capital :
Middle East Pharmaceutical Industries Co
1st and 2nd Floor, Lavida Building, Al Sulaymaniyah District, Riyadh, Riyadh, Saudi Arabia
+966 11 4653144

Reports

Date Title File
AVALON PHARMA Quarterly Financials Report Q1 2024
Avalon delivers strong start to 2024 with a remarkable 37% increase in revenue, high profitability and substantial rise in net profit
AVALON PHARMA Annual Financials Report 2023
Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces the Final Offer Price
Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces its IPO Offer Price Range and Commencement of Institutional Book Building
Middle East Pharmaceutical Industries Company (“Avalon Pharma”) Announces its Intention to Float on the Saudi Exchange’s Main Market
AVALON PHARMA Quarterly Financials Report Q2 2023
AVALON PHARMA Annual Financials Report 2022
AVALON PHARMA Annual Financials Report 2021
AVALON PHARMA Annual Financials Report 2020
Check our coverage for Saudi Arabia